Payment Data Systems $PYDS Reports Financials, Stock Responds Positively

Payment Data Systems Inc. (PYDS), a major player in card payment processing segment, announced its fourth quarter and full year results for 2016. The financial results were a little concerning, as the company reported higher than before net loss, as well as decline in its revenue. However, the investors with medium to long term horizon are required to have vision which goes beyond short-term results. paymentdatasystems-650x535Despite the dip in its margins, the company still remains strong with stout reserves and fundamentals.   The results also looked slightly disappointing, as the company is now competing against the high bar it has set up for itself. Read more


The Movie Studio $MVES to Release 12 Films to India, Middle East & Neighboring Territories

The Movie Studio, Inc. ( OTC PINK : MVES ) (“TMS” or the “Company”), is a vertically integrated motion picture production and distribution company with 18 completed motion pictures, 12 under acquisition, production and distribution assets.

The Movie Studio, Inc. is pleased to make its first announcement from The Berlin Film Festival. On February 12th 2017 the Company executed a new distribution partnership with KRISCO Media FZC of DUBAI United Arab Emirates through distribution Agreement with Cinema Arts Entertainment/Artedis.

Read more

Payment Data Systems $PYDS Initiates Strategic Acquisition of Singular Payments

The global payment system is undergoing a tectonic change with the swift change in technology. The changes are resulting in new challenges as well as in opportunities. Traditionally, the system engaged the services of a niche group of stakeholders consisting of cardholders, businespaymentdatasystems-650x535ses and concerned banks. The critical link between these stakeholders is a payment processor and this is where Payment Data Systems Inc. (NASDAQ:PYDS) enters the scene. A processor is essential for ensuring that there is proper information flow between the acquirer bank and card issuing bank. Payment Data Systems is a third party processor system which changed the face of the payment processing industry with the innovative use of technological tools. Read more


Payment Data Systems $PYDS Reports Strong Quarterly Numbers

Countries all over the world are moving towards a cashless economy. The trend is expected to gain strength as technology keeps evolving to support the large volume of transactions. Another factor which will drive online payment system further is the rise of e-commerce. All electronic transapaymentdatasystems-650x535ctions as well as offline transactions involving different bank cards require the services of processing companies for executing payment instructions.

Payment Data Systems Inc. (NASDAQ:PYDS), based out of San Antonio, Texas, offers integrated payment processing services. Its portfolio of services includes different types of automated clearing house (ACH) processing, and credit, prepaid card, and debit card-based processing services. Read more


The Movie Studio $MVES – Hollywood’s Newest Brand – Expands Market to China

The global entertainment sector is expected to see a lot of action this year. New formats of delivery have dealt a blow to traditional cinema viewing. The domestic US market is also showing signs of saturation. Movie studios are now exploring new options to deal with such scenarios. One noticeable trend in the last few years has been the move of Hollywood studios towards the East, particularly China.

The Movie Studio Inc. (OTC PINK: MVES) grabbed a slice of the growing China market as it recently announced its new distribution deal with Wing Sight International Media of Beijing. The deal was carried out through Cinema Arts Entertainment and became effective on January 1, 2017 with an initial term of 5 years. Read more

The Movie Studio $MVES Signs Deal to Enter China Movie Market


  • The Movie Studio is extending its global presence across China to offset declining US sales.

  • China is slated to outpace the US market in 2-3 years.

  • MVES is strategically positioned to take advantage of the Chinese growth story.

The global entertainment sector is expected to see a lot of action this year. Print New formats of delivery have dealt a blow to traditional cinema viewing. The domestic US market is also showing signs of saturation. Movie studios are now exploring new options to deal with such scenarios. One noticeable trend in the last few years has been the move of Hollywood studios towards the East, particularly China. Read more

Payment Data Systems Targeting Growth in 2017

Digital payment processing is an emerging, growing market, with China and the US leading the market in terms of volume. paymentdatasystems-650x535 It is growing at a tremendous rate compared to other forms of payments and money transfers, as the following chart shows:

WFM_1.30.2107 Read more

Payment Data Systems $PYDS A Small Cap FinTech Growth Opportunity

The payment processing industry is becoming increasingly complex with the onslaught of new entrants and technologies. paymentdatasystems-650x535 The main players in this segment offers services such as processing of transactions carried out using cards including ACH, credit, debit, and gift cards. These service providers also offer value added functions such as balance sufficiency checks and related data.

One of the key players in this segment is Payment Data Systems Inc. (NASDAQ:PYDS). This San Antonio based company collaborates with major card companies such as MasterCard (NYSE:MA), VISA (NYSE:V), Discover (NYSE:DFS), and JCB Networks. Since the company’s strong-suit is in online transactions such as card-not-present transactions, it is well positioned to benefit from increasing e-commerce. Read more

Actinium Pharmaceuticals $ATNM Another Promising Name In The AML Space

While this has been a mixed year for the biotechnology sector, there have been some clear winners. Celator Pharmaceuticals Inc. (NASDAQ: CPXX) is one such winner. In fact, CPXX is one of the most phenomenal stories in the biotech sector this year. paymentdatasystems-650x535 Before it was acquired by Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) earlier in the year, CPXX returned investors more than 1600% this year.

The phenomenal run in CPXX began in March this year after the company announced top-line results for its lead product candidate VYXEOS. When the company released expanded data for the lead product candidate, shares jumped another 50%. In May this year, CPXX agreed to be acquired by Jazz for more than $30 per share. From just above $1.50 per share to more than $30 per share within a matter of months. Read more

Actinium Pharmaceuticals $ATNM Further Strengthens IP Portfolio: Memorial Sloan Kettering (MSK)

Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or the “Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers paymentdatasystems-650x535 , announced today that the Company has been assigned two provisional patent applications from Memorial Sloan-Kettering Cancer Center (MSK). The Company’s License, Development and Commercialization Agreement (License Agreement) with MSK, which already included issued patents that pertain to Actinium’s Alpha Particle Immunotherapy (APIT) technology platform and drug preparation methods now includes these newly assigned provisional patent applications. Read more

Payment Data Systems: A High Risk/Reward Opportunity In The Mobile Payments Space

The investment case for Payment Data Systems Inc. (NASDAQ: PYDS) is pretty straightforward. The mobile payments industry has been seeing phenomenal growth, driven by increasing use of smartphones and tablets. paymentdatasystems-650x535 This substantial growth has attracted the attention of even conventional payment processing companies such as Visa Inc. (NYSE: V) and MasterCard Incorporated (NYSE: MA). Indeed, we have seen consolidation in the mobile payments industry in recent years and PYDS remains one of the few takeover targets left. Read more



Actinium Pharmaceuticals $ATNM: A Hidden Gem in the Biotech Sector

Celator Pharmaceuticals Inc. (NASDAQ: CPXX) has been one of the biggest gainers in the biotech sector this year. Year-to-date, CPXX has gained more than 1600%. Some of the gains have come recentlypaymentdatasystems-650x535 after the company agreed to be acquired by Jazz Pharmaceuticals (NASDAQ: JAZZ). But even before the acquisition news came, CPXX had logged in substantial gains. The reason behind the rally in CPXX has been positive top-line results from its Phase 3 clinical trial evaluating its lead product candidate VYXEOS(TM) in patients with high-risk (secondary) acute myeloid leukemia (AML) compared to the standard of care. The question is whether there is any other opportunity like CPXX in the market right now.Read more

The Mobile Payments Industry Is Seeing Consolidation, Could PYDS Be Next?

Payment Data Systems Inc. (NASDAQ: PYDS) is a San Antonio, Texas processor of electronic payments for other companies. paymentdatasystems-650x535PYDS generates revenue across the payment processing value chain. The company has seen substantial increase in its transactions processed per year in the last five years.
PYDS also has partnerships with some of the biggest names in Corporate America. PYDS is an emerging player in the fast growing mobile payments industry.

Read more

Actinium Pharmaceuticals $ATNM Remains Significantly Undervalued

The biotech sector has seen a sharp correction since late April. Since April 25th, the iShares NASDAQ Biotechnology Index (ETF) (IBB) has dropped more than 12%. If the sell-off continues over the next week, the biotech sector could very well end up in bear market territory.actinium logo

The sharp correction in the biotech sector though has also created some excellent buying opportunities. Indeed, some advanced clinical stage companies now look substantially undervalued. One such company is Actinium Pharmaceuticals Inc. (NYSEMKT: ATNM). Read more

Payment Data Systems $PYDS Launches Kind Hand Solutions Platform for Churches and Charitable Organizations

Payment Data Systems, Inc.(PYDS) today announced its launch of Kind Hand, a giving and registration management solution for churches and charitable organizations built on Spark Development Network’s Rock RMS open source system.

“We are excited to introduce Kind Hand, which is the first of our vertical solutions for church communities and non-profits that is built on the Rock RMS platform,” said Louis Hoch, president and chief operating officer of Payment Data Systems.Read more

Payment Data Systems $PYDS Announces Growth in Credit Card Transactions for Q1 2016

Payment Data Systems, Inc. (PYDS), an integrated electronic payments solutions provider, announced today its transactions processing volumes for the first quarter of 2016. paymentdatasystems-650x535

Credit card transaction processing volume and credit card dollars processed in the first quarter increased 6% and 5%, respectively, over the same time period in 2015.

ACH (eCheck) transaction volume during first quarter of 2016 decreased 11% from the first quarter of 2015. Read more

Payment Data Systems $PYDS Offers Significant Upside

The phenomenal growth experienced by the mobile payments industry over the last few years has generated significant interest in the industry. actinium logo The industry has seen consolidation since 2014. The growth in the mobile payments industry has been driven by the increasing use of smartphones and tablets.

Growing Interest

In 2014, Intuit Inc. (NASDAQ: INTU) announced the acquisition of Check, a mobile payments startup, for $360 million. Read more

Why Actinium Pharma $ATNM Offers Favorable Risk/Reward Profile

2016 has so far turned out to be a challenging year for the biotechnology sector. actinium logo The sector saw two sell-offs in 2015 but managed to finish the year on a strong note. However, the start of this year can be termed as nothing but disastrous for the sector. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) dropped to a 52-week low earlier this year. However, the sell-off has created an excellent opportunity to buy. Read more

Actinium $ATNM Receives Orphan Drug Designation From FDA for Iomab-B in Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients

Orphan Drug Designation Anticipated to Provide Faster Regulatory Review, Financial Incentives and Market Exclusivity Read more

Payment Data Systems $PYDS: Why This Mobile Payments Company Should Be On Your Radar

The mobile payments industry has been seeing significant growth, driven mainly by the increasing use of smartphones and tablets. Indeed, the industry has even piqued the interest of electronics payment giants such as Visa Inc. (NYSE: V) and MasterCard Inc. (NYSE: MA).Read more

Payment Data Systems $PYDS Announces Record Transaction Processing Results for the Fourth Quarter and Year Ended December 31, 2015

Introduces New eCheck Verification Service That Helps Merchants Prevent Returns Before Processing, Which Improves Quality of the ACH Network by Reducing Return Transactions

Payment Data Systems (PYDS), an integrated payment solutions provider, today announced transaction processing results for the fourth quarter and year ended December 31, 2015.Read more

Actinium Pharmaceuticals: A Small Cap Stock To Watch In The Biotech Space

actinium logoThe biotechnology sector has seen a multi-year rally that came to a halt only in mid-2015. However, the correction did not last long as the sector has seen a recovery in the last three months. The rebound highlights the fact that the sector remains robust.

Indeed, 2015 saw a record number of deals announced in the biotech sector. There were also a record number of FDA approvals in 2015.Read more

Payment Data Systems $PYDS: A Significantly Undervalued Company In The Payments Processing Industry

The growth of e-commerce has boosted the outlook for the payments processing industry. Within the payment processing industry, mobile payments is one of the fastest growing areas. This does not come as a surprise given the increasing use of smartphones and tablets.

Global Payments Inc. (NYSE: GPN) is one of the biggest providers of payment and digital commerce solutions. GPN currently has a market capitalization of almost $9 billion. The company had net income of $289.32 million for the trailing Read more

Actinium Announces Iomab-B IND Has Been Cleared By FDA; Pivotal, Phase 3 Trial to Proceed

actinium logo

NEW YORK, NY–(Marketwired – December 17, 2015) – Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. The Company announced today that the FDA has cleared the Company’s IND filing for Iomab-B, and that it will proceed with the pivotal, Phase 3 clinical trial. Actinium anticipates the Phase 3, controlled, randomized, pivotal trial to begin enrolling in the first half of 2016 and assuming that the trial meets its end points, it will form the basis for a Biologics Licensing Application (BLA). Actinium also indicated that it will update investors with further details on the company’s pipeline including new programs and product candidates Read more

Payment Data Systems $PYDS Well Positioned In Mobile Payments Industry

actinium logo

According to a report on the mobile payments industry, Business Insider notes that mobile transactions accounted for around 2% of all credit and debit card volume in the U.S. in 2013. Globally, mobile transactions accounted for around 4%, according to the same report.

While these numbers are not very high, it is the growth that should be taken note of. According to Business Insider, in the U.S. alone, mobile transactions have seen growth of 118% over the last few years. This does not come as a surprise considering the increasing use of smartphones and tablets and increasing Internet penetration globally.Read more